Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience
We report our first clinical experience with a CE-marked flexible monorail balloon-expandable stent for treatment of high-grade intracranial stenoses.
Between April 2006 and November 2007 21 patients with symptomatic intracranial stenoses (>70%) were treated with the PHAROS stent. In seven patients, the procedure was performed during acute stroke intervention. Procedural success, clinical complication rates and mid-term follow-up data were prospectively recorded.
During a median follow-up period of 7.3 months one additional patient died of an unknown cause 3 months after the intervention. A patient with a significant residual stenosis presented with a new stroke after further progression of the residual stenosis. None of the successfully treated patients experienced ipsilateral stroke.
Recanalization of intracranial stenoses with the balloon-expandable Pharos stent is technically feasible. The periprocedural complication rate and mid-term follow-up results were in the range of previously reported case series. This pilot study was limited by the small sample size and severe morbidity of the included patients. Final evaluation of the efficacy of Pharos stent treatment demands further investigation.
KeywordsIntracranial stenosis Intracranial stenting Pharos stent Balloon-expandable stent
Conflict of interest statement
Professor Berkefeld is principal investigator of the German Pharos registry and consultant of Micrus endovascular in this regard.
- 2.Higashida RT, Meyers PM, Connors JJ 3rd, Sacks D, Strother CM, Barr JD, Wojak JC, Duckwiler GR; American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Society of Neuroradiology (2005) Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. AJNR Am J Neuroradiol 26:2323–2327PubMedGoogle Scholar
- 15.Levy EI, Turk A, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rassmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ (2007) Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 61:644–651PubMedCrossRefGoogle Scholar
- 16.Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chatuverdi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators (2006) Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113:555–563PubMedCrossRefGoogle Scholar
- 23.US Food and Drug Administration (2008) Premarket Approval (PMA) Database, No. P030037. Center for Devices and Radiological Health. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/PMA.cfm?ID=2969
- 25.Cruz-Flores S, Diamond AL (2006) Angioplasty for intracranial artery stenosis. Cochrane Database of Systematic Reviews, issue 3, article no.: CD004133. DOI 10.1002/14651858.CD004133.pub2